Consolidated Statements of Operations (USD $)	3 Months Ended		149 Months Ended
	Mar. 31, 2012	Mar. 31, 2011	Mar. 31, 2012
NET REVENUES
Sales	$ 3,740	$ 900	$ 457,866
Royalties	10,000	1,890	645,180
TOTAL NET REVENUE	13,740	2,790	1,103,046
COST OF SALES	2,036	373	426,984
GROSS PROFIT	11,704	2,417	676,062
OPERATING EXPENSES
Research and development	1,257		863,629
Patent costs			65,000
Legal and Accounting	90,347	9,969	1,352,359
Sales and Marketing	48,308	51,778	5,479,277
General and administrative	35,690	39,781	3,772,245
Total operating expenses	175,602	101,528	11,532,510
LOSS BEFORE OTHER INCOME	(163,898)	(99,111)	(10,856,448)
OTHER INCOME (EXPENSE)
Interest income		51	63,663
Interest expense	(71,707)	(84,173)	(1,984,768)
Gain on debt forgiveness			184,242
Gain on disposition of assets			4,722
Total Other Income (Expense)	(71,707)	(84,122)	(1,732,141)
LOSS BEFORE INCOME TAX BENEFIT	(235,605)	(183,233)	(12,588,589)
INCOME TAX BENEFIT			(165,000)
NET LOSS	$ (235,605)	$ (183,233)	$ (12,423,589)
BASIC AND DILUTED NET LOSS PER COMMON SHARE	$ 0.00	$ 0.00
BASIC AND DILUTED WEIGHTED AVERAGE COMMON SHARES OUTSTANDING	145,144,603	155,673,839